Sign in
4

Changes in Ownership

FATE THERAPEUTICS INC Filed Acc 0001104659-24-038585

Options or other derivatives

  • Director acquired 3,636,364 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Redmile Group, LLC Director 2024-03-21 Grant or award · Pre-Funded Warrants to Purchase Common Stock +3,636,364 $5.50 $19,996,366 3,893,674 I
Loading xslF345X05/tm249642-1_4seq1.xml…